This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

This Week's IPO Winners and Losers

NEW YORK ( TheStreet -- Many Chinese IPOs have seen success in the aftermarket, and Mecox Lane Limited (MCOX), which debuted on the Nasdaq exchange Tuesday was no exception.

The Shanghai-based online apparel retailer priced an offering of 11.7 million shares at $11 each, and saw the stock rocket almost 60% to close at $17.26.

Mecox's surge follows the market's warm reception of Country Style Cooking Restaurant (CCSC - Get Report), the Chinese fast food chain that began trading at $24 in September and currently changes hands at roughly $34 a share for a gain for 38%.

Another example is China New Borun (BORN - Get Report), which sells alcoholic beverages. The company went public in June at $7 per share and the stock now trades at around $16, a whopping 140% gain.

Then there's the rare earth mineral company Molycorp (MCP - Get Report), that has soared to $35 from its original price of $12.

But with every IPO success story, Chinese or no, there seems to an equally dismal offering.

One such name is NuPathe (PATH), a pharmaceutical company that launched in August at $10 a share and has sunk to $6.

Trius Therapeutics (TSRX) hasn't fared much better as it dropped from an initial $5 a share to $4 for a 20% decline.

But it's not just small drug companies that have fallen flat. SMART Technologies (SMT - Get Report) went public at $17 and has tumbled to $13.50, also a 20% loss.

So investors need to do a little homework if they want to informed decisions about these IPOs. Here are this week's offerings and their chances of success.
1 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
TSRX $0.00 0.00%
PATH $0.00 0.00%
BORN $1.17 -4.10%
CCSC $4.77 -8.40%
EXAM $39.22 0.49%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs